Research study to find out if #SSRI sertraline is better than placebo for treating anxiety in #autistic adults. Now closed to new expressions of interest.
The SerTRaline for AnxieTy in adults with a diagnosis of Autism (STRATA) study aims to assess whether Sertraline reduces anxiety & improves autistic adults' quality of life.
STRATA is funded by @NIHRresearch, and receives no funding from pharmaceutical companies (1/5)
NEW 🚨 Now available as a pre-print:
"Implementation of the QuinteT Recruitment Intervention to facilitate recruitment in a placebo-controlled complex trial with autistic adults" https://t.co/wUcw6UWm80
The STRATA Central Research Team would like to warmly thank all presenters and attendees.
Updates on our publications will be available here: https://t.co/zLsP8SrQSX
(4/4)
After several years of work, over 40 researchers, clinicians, & members of our Autistic Advisory Group met at the @BristolUni Medical School for the STRATA results reveal (n.b. the main trial results are currently embargoed outside of this group)... (1/4)
... hearing from our Autistic Advisory Group about their experiences of being involved in STRATA, from initial conception all the way back in 2018 to the present day, learning the main results of the trial, and discussing potential implications for clinical practice (3/4)
As we analyse the data from the STRATA trial, you can read our publications as they are published here: https://t.co/zLsP8SsoIv
Protocol paper: https://t.co/bKHMdJh2R3
As we analyse the data from the STRATA trial, you can read our publications as they are published here: https://t.co/zLsP8SsoIv
Protocol paper: https://t.co/bKHMdJh2R3
We are now able to share that all data collection has been finalised on STRATA, and the data are now being analysed.
We are looking forward to being able to share the results of the study in 2025.
Special thanks to our @BristolStrata advisory group who celebrated their 6th year supporting all aspects of the study - from conception, now to planning dissemination. Thanks @Autistica for helping set up the group in 2018- still going strong!
In addition, over half our our participants have now completed their participation in the study, reaching week 52.
Data collection for the trial is expected to be complete by the end of October 2024.
This means that 92% of our participants in the STRATA trial returned the main questionnaire 16 weeks after enrollment. This asks key questions about participants' mental health, which will be used to determine whether sertraline is effective in treating anxiety in autistic adults
Sertraline for anxiety in adults with a diagnosis of autism
Read the STRATA study protocol published in #Trialsjournal@BristolStrata#ISRCTN: https://t.co/fJR5Z0Pfu7
https://t.co/aWPENisy7Y
WE DID IT. 4 weeks ahead of target and 12 more participants than planned (to respect commitment of those whose GP checks were in process whe we reached required 306). Now 12 months of follow up of our last participant before we work on results. More facts and figures to follow 🎊
DELIGHTED to announce that @BristolStrata has completed recruitment. 318 autistic adults randomised to sertraline/placebo. 🙏 to our participants, advisory group, trial team, sites, researchers, PIs/prescribers, funders, and supporters! @NIHRresearch@nhmrc@BrsTrialsCentre
DELIGHTED to announce that @BristolStrata has completed recruitment. 318 autistic adults randomised to sertraline/placebo. 🙏 to our participants, advisory group, trial team, sites, researchers, PIs/prescribers, funders, and supporters! @NIHRresearch@nhmrc@BrsTrialsCentre